Cargando…

Anticytokine Therapies in Severe Coronavirus Disease 2019 Should Be Informed by Detailed Inflammatory Profiling and Specific Therapeutic Targets

Detalles Bibliográficos
Autores principales:	Slessarev, Marat, Fraser, Douglas D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566861/ https://www.ncbi.nlm.nih.gov/pubmed/33134941 http://dx.doi.org/10.1097/CCE.0000000000000246

Ejemplares similares

Comparison of Anakinra and Tocilizumab in Anticytokine Therapy in the Treatment of Coronavirus Disease-2019
por: Ozkan, Feyza, et al.
Publicado: (2022)

Viral Anticytokine Strategies
por: Alcami, Antonio
Publicado: (2016)

Profiling Serum Cytokines and Anticytokine Antibodies in Psoriasis Patients
por: Hong, Dan, et al.
Publicado: (2022)

Update on Anticytokine Treatment for Asthma
por: Gallelli, Luca, et al.
Publicado: (2013)

Anticytokine Autoantibodies and Fungal Infections
por: Kappagoda, Shanthi, et al.
Publicado: (2023)

Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients
por: Fraser, Douglas D., et al.
Publicado: (2020)

Detection and Profiling of Human Coronavirus Immunoglobulins in Critically Ill Coronavirus Disease 2019 Patients
por: Fraser, Douglas D., et al.
Publicado: (2021)

Anticytokine Autoantibodies: Association with Infection and Immune Dysregulation
por: Knight, Vijaya, et al.
Publicado: (2016)

Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers
por: Fraser, Douglas D., et al.
Publicado: (2020)

Anticytokine therapy for periodontal diseases: Where are we now?
por: Waykole, Yogesh Prakash, et al.
Publicado: (2009)

Preventing COVID-19-induced pneumonia with anticytokine therapy
por: Monteleone, Giovanni, et al.
Publicado: (2020)

Frugal Innovation: Enabling Mechanical Ventilation During Coronavirus Disease 2019 Pandemic in Resource-Limited Settings
por: Dave, Chintan, et al.
Publicado: (2021)

Anticytokine autoantibodies leading to infection: early recognition, diagnosis and treatment options
por: Barcenas-Morales, Gabriela, et al.
Publicado: (2019)

A genome-engineered bioartificial implant for autoregulated anticytokine drug delivery
por: Choi, Yun-Rak, et al.
Publicado: (2021)

Coronavirus Disease 2019 or Lung Cancer: What Should We Treat?
por: Russano, Marco, et al.
Publicado: (2020)

How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology
por: Jessica Chang, Ting Yi, et al.
Publicado: (2020)

SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
por: Simon, David, et al.
Publicado: (2021)

What special considerations should acute appendicitis bring to the clinician in the midst of Coronavirus Disease 2019
por: Yu, Xianqiang
Publicado: (2021)

Endothelial Injury and Glycocalyx Degradation in Critically Ill Coronavirus Disease 2019 Patients: Implications for Microvascular Platelet Aggregation
por: Fraser, Douglas D., et al.
Publicado: (2020)

Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients
por: Fraser, Douglas D., et al.
Publicado: (2020)

Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia
Publicado: (1990)

Targeting miR-18a sensitizes chondrocytes to anticytokine therapy to prevent osteoarthritis progression
por: Lian, Chengjie, et al.
Publicado: (2020)

Fraxin in Combination with Dexamethasone Attenuates LPS-Induced Liver and Heart Injury and Their Anticytokine Activity in Mice
por: Shaker, Nada Sahib, et al.
Publicado: (2023)

Severe coronavirus disease 2019 in children and young adults
por: Wilkes, Meredith, et al.
Publicado: (2020)

Platelet count in patients with severe coronavirus disease 2019
por: Kawada, Tomoyuki
Publicado: (2021)

Lymphocytes and Eosinophils Associated with the Coronavirus Disease-2019 Severity
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Should we avoid colleagues in leisure time during the coronavirus disease 2019 (COVID-19) pandemic?
por: Oksanen, Lotta-Maria A. H., et al.
Publicado: (2020)

Immunothrombosis Biomarkers for Distinguishing Coronavirus Disease 2019 Patients From Noncoronavirus Disease Septic Patients With Pneumonia and for Predicting ICU Mortality
por: Cani, Erblin, et al.
Publicado: (2021)

Targeting complement in severe coronavirus disease 2019 to address microthrombosis
por: Valga, Francisco, et al.
Publicado: (2020)

Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia
por: Lahmer, T., et al.
Publicado: (2020)

Modulation of T Cell Function by Combination of Epitope Specific and Low Dose Anticytokine Therapy Controls Autoimmune Arthritis
por: Roord, Sarah T.A., et al.
Publicado: (2006)

Coronavirus disease 2019, Kawasaki disease, and multisystem inflammatory syndrome in children
por: Bassareo, Pier Paolo, et al.
Publicado: (2020)

The role of a cytokine storm in severe coronavirus disease 2019 in pregnancy
por: Wang, Xiaoping, et al.
Publicado: (2020)

Dementia is Associated with Severe Coronavirus Disease 2019 (COVID-19) Infection
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2021)

Albumin and total bilirubin for severity and mortality in coronavirus disease 2019 patients
por: Wang, Ying, et al.
Publicado: (2020)

Hemoglobin value may be decreased in patients with severe coronavirus disease 2019
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Cardiopulmonary Ultrasonography for Severe Coronavirus Disease 2019 Patients in Prone Position
por: Rali, Aniket S, et al.
Publicado: (2020)

COVID‐19 plasma proteome reveals novel temporal and cell‐specific signatures for disease severity and high‐precision disease management
por: Iosef, Cristiana, et al.
Publicado: (2022)

Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape
por: Papa, Alfredo, et al.
Publicado: (2021)

Should We Continue or Discontinue Inflammatory Bowel Disease Medication in Patients With Coronavirus Disease 2019?
por: Hayashi, Yuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_len8llvh2ftk07i3b250ai107u